Advance Zinctek Limited · ASX:ANO

Advance Zinctek — Shareholder Meeting (October 2023)

15 slides from Advance Zinctek's shareholder meeting presentation, Oct 9, 2023

  1. Slide 1: Market Update: Monetising Our Capital Investment

    “36 various skin For personal use only cancer procedures – For me it’s not just business, it’s Advance personal” ZincTek Ltd Market Update Monetising Our Capital Investment Managing Director for ANO, Geoff Acton Appointed March 2016 October 9 2023

  2. Slide 2: Company Highlights

    COMPANY HIGHLIGHTS • We have contained costs over the past 3 years and maintained pricing at 2020 levels. Unfortunately, it appears that our inexperience dealing with For personal use only distributors has allowed them to increase margins particularly in the US. • Profit after tax FY23 $1.663 millio

  3. Slide 3: Current 1st Half Sales

    CURRENT 1st HALF SALES For personal use only 1st Half FY23 1st Half FY24 $AUD6.671 million $AUD6.961 million (Estimated) Key Points: • Our US Distributor is behind $AUD2.9 million in their minimum calendar year sales volumes as per their signed agreement and in September 2023 moved $AUD2.5 million o

  4. Slide 4: ANO Wages/Electricity Performance Review

    ANO WAGES/ ELECTRICITY PERFORMANCE REVIEW The calculation of gross wages as a percentage of total revenue including the fluctuations in finished goods, is set out below. For personal use only FY22 FY23 AUD AUD Revenue $12.504 million $13.745 million Stock Movement Finished Goods (2.185 million) 2.21

  5. Slide 5: Revenue & Key Expenses 2022 vs 2023

    REVENUE & KEY EXPENSES 2022 VS 2023 For personal use only FY22 FY23 Gross Margin* 58.6% 58.6% Rent as a % of revenue 4.1% 4.3% Corporate Costs as a % of revenue (including Audit/ ASX 2.7% 1.9% fees) Depreciation & Amoritsation as a % of revenue 7.9% 9.2% CEO & Directors Fees as a % of revenue 2.8% 2

  6. Slide 6: Company Snapshot FY22 vs FY23

    COMPANY SNAPSHOP FY22 VS FY23 FY22 $AUD FY23 $AUD FY22 $AUD FY23 $AUD For personal use only Million Million Million Million Profit (Loss) Before Tax Statutory Results Adjusted Results 3.682 2.291 2.298 2.844 Revenue 12.504 million 13.745 million 11.668 million 14.581 million Current Assets 17.951 m

  7. Slide 7: Continue to Grow the Number of Distributors in Europe/Asia/South America

    MONETISING SPARE CAPACITY CONTINUE TO GROW THE NUMBER OF DISTRIBUTORS IN EUROPE/ ASIA/ SOUTH AMERICA • Diversify our product sales across multiple markets to increase sales revenue and reduce the revenue exposure from 2 major distributors For personal use only • Target new distributors in 27 countri

  8. Slide 8: Target New Alternative Markets for Non USP Grade Zinc Oxide

    MONETISING SPARE CAPACITY TARGET NEW ALTERNATIVE MARKETS FOR NON USP GRADE ZINC OXIDE • To increase our sales and utilise our 5,000MT capacity to diversify our product into multiple market segments reducing our exposure to fluctuations in the For personal use only personal care sector. • By targetin

  9. Slide 9: Provide Formulation Recipes and Full Test Results to Potential Users

    MONETISING SPARE CAPACITY PROVIDE FORMULATION RECIPES AND FULL TEST RESULTS TO POTENTIAL USERS • Increase income by allowing much more rapid adoption of our active ingredients, providing manufacturers and brand owners with ready made end For personal use only product solutions. • Offering innovative

  10. Slide 10: Introduce New Organic/Vegan Oils Expanding Our Dispersion Range

    MONETISING SPARE CAPACITY INTRODUCE NEW ORGANIC/VEGAN OILS EXPANDING OUR DISPERSION RANGE • To increase our revenue in dispersions and utilise our 800MT dispersion capacity. For personal use only • Provide brand owners, and manufacturers with multiple dispersion alternatives to produce a range of en

  11. Slide 11: Leverage Our Bulk Buying Power to Supply Additional New Ingredients

    MONETISING SPARE CAPACITY LEVERAGE OUR BULK BUYING POWER TO SUPPLY ADDITIONAL NEW INGREDIENTS INTO THE AUSTRALIAN MARKET • For personal use only Increase revenue and gross margins, by promoting and selling already available raw ingredient stock. • Introducing lower cost ingredients into the Australi

  12. Slide 12: Alusion Product Development

    MONETISING SPARE CAPACITY ALUSION PRODUCT DEVELOPMENT For personal use only • Our latest trials of high purity Alusion with new precursor are promising. The investment in the new equipment will change our manufacturing process and will result in a reduction in price and open new opportunities in mul

  13. Slide 13: Initiatives Already in Place

    MONETISING SPARE CAPACITY INITIATIVES ALREADY IN PLACE Centralise Worldwide Technical And Formulation Support For New End-user Promote Range Of “EcoZinc” – ZinClear XP – 100% Enquiries. Powered By The Sun, Powders And Dispersions For personal use only Number of Enquiries Products Requested Number of

  14. Slide 14: Enable Brand Owners to Obtain Endorsements by Leading Dermatologist

    MONETISING SPARE CAPACITY ENABLE BRAND OWNERS TO OBTAIN ENDORSEMENTS BY LEADING DERMATOLOGIST DR. RUSSELL HILLS Dr Russell Hills – Sunscreen For personal use only Safety Basics M.B.B.S. (QLD). F.A.C.D., F.A.C.C.S. Dermatologist and Cosmetic Dermatologic Surgery, Member of The Australasian Academy of

  15. Slide 15: Disclosures Regarding Forward Looking Statements

    DISCLOSURES REGARDING FORWARD LOOKING STATEMENTS For personal use only • This Market Statement includes forward-looking statements that have been based on Advance ZincTek’s current expectations and predictions about future events including Advance ZincTek’s intentions. • These forward-looking statem

Advance ZincTek — Shareholder Meeting (October 2023) on 6ix